Showing results (101-110 of 112) with videos related to

Sort By:
Pageof 12
AIDS and Behavior|January 8, 2025
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational StudyV Iannone, F Lombardi, A Ciccullo, et al.
The Journal of Antimicrobial Chemotherapy|April 18, 2015
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot studyA Mondi, M Fabbiani, N Ciccarelli, et al.
HIV Medicine|January 31, 2018
An outbreak of acute hepatitis A among young adult men: clinical features and HIV coinfection rate from a large teaching hospital in Rome, ItalyA Ciccullo, R Gagliardini, G Baldin, et al.
Epidemiology and Infection|March 15, 2019
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016S Bellino, A Borghetti, F Lombardi, et al.
HIV Medicine|June 27, 2019
Lamivudine-based maintenance antiretroviral therapies in patients living with HIV-1 with suppressed HIV RNA: derivation of a predictive score for virological failureA Borghetti, D Moschese, A Cingolani, et al.
Heart (British Cardiac Society)|November 17, 2001
Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiographyF B Sozzi, D Poldermans, J J Bax, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 1, 1994
Quality of life after cardiomyoplastyS A Borghetti-Maio, B W Romano, E A Bocchi, et al.
HIV Medicine|March 25, 2018
Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replicationA Borghetti, G Baldin, F Lombardi, et al.
HIV Medicine|September 23, 2020
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitorsA Borghetti, A Ciccullo, F Lombardi, et al.
Antiviral Therapy|December 19, 2024
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohortR A Passerotto, F Lamanna, P F Salvo, et al.
Pageof 12